Literature DB >> 29356877

Cervical Cancer Induction Enhancement Potential of Chlamydia Trachomatis: A Systematic Review.

Safae Karim1,2, Tiatou Souho3, Mohamed Benlemlih2, Bahia Bennani4,5.   

Abstract

Human papillomavirus (HPV) persistent infection is the necessary but not sufficient cause of cervical cancer. Other co-factors are required to induce cell transformation that will evolve to malignant cervical cancer. These co-factors include physical elements, other sexually transmitted infections, and immune response. Chlamydia trachomatis the most common bacterial sexually transmitted infection is often asymptomatic but causes various syndromes such as cervicitis, endometritis, pelvic inflammatory disease, and infertility. It is established that this bacterium is involved in cell proliferation process and inhibit apoptosis. Furthermore, C. trachomatis may induce chronic inflammation, interfere with immune response by decreasing the number of antigen presenting cells, and reduce the cell-mediated immunity allowing the persistence of HPV. However, it is unclear whether this bacterium plays a particular role in cervical cancer induction. We therefore aimed at enlightening the actual knowledge about the relationship between C. trachomatis and cervical cancer or precursor lesions through a systematic literature review. We summarized and analyzed the epidemiological data on C. trachomatis and its co-infection with HPV and their association to cervical cancer.

Entities:  

Mesh:

Year:  2018        PMID: 29356877     DOI: 10.1007/s00284-018-1439-7

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  57 in total

Review 1.  Chlamydia trachomatis infections of the female genital tract: state of the art.

Authors:  Jorma Paavonen
Journal:  Ann Med       Date:  2011-02-01       Impact factor: 4.709

2.  Chlamydia trachomatis infection in women with and without cervical intraepithelial neoplasia.

Authors:  I Takac; B Gorisek
Journal:  Int J STD AIDS       Date:  1999-05       Impact factor: 1.359

3.  A loss-of-function screen reveals Ras- and Raf-independent MEK-ERK signaling during Chlamydia trachomatis infection.

Authors:  Rajendra Kumar Gurumurthy; André P Mäurer; Nikolaus Machuy; Simone Hess; Klaus P Pleissner; Johannes Schuchhardt; Thomas Rudel; Thomas F Meyer
Journal:  Sci Signal       Date:  2010-03-16       Impact factor: 8.192

4.  Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.

Authors:  Margaret M Madeleine; Tarja Anttila; Stephen M Schwartz; Pekka Saikku; Maija Leinonen; Joseph J Carter; Michelle Wurscher; Lisa G Johnson; Denise A Galloway; Janet R Daling
Journal:  Int J Cancer       Date:  2007-02-01       Impact factor: 7.396

5.  Human Papillomaviruses and genital co-infections in gynaecological outpatients.

Authors:  Rosita Verteramo; Alessandra Pierangeli; Emanuela Mancini; Ettore Calzolari; Mauro Bucci; John Osborn; Rosa Nicosia; Fernanda Chiarini; Guido Antonelli; Anna Marta Degener
Journal:  BMC Infect Dis       Date:  2009-02-12       Impact factor: 3.090

6.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.

Authors:  L A Koutsky; K K Holmes; C W Critchlow; C E Stevens; J Paavonen; A M Beckmann; T A DeRouen; D A Galloway; D Vernon; N B Kiviat
Journal:  N Engl J Med       Date:  1992-10-29       Impact factor: 91.245

7.  Molecular detection of HPV and Chlamydia trachomatis infections in Brazilian women with abnormal cervical cytology.

Authors:  André L P de Abreu; Paula R B Nogara; Raquel P Souza; Mariana C da Silva; Nelson S Uchimura; Rodrigo L Zanko; Erika C Ferreira; Maria C B Tognim; Jorge J V Teixeira; Fabrícia Gimenes; Marcia E L Consolaro
Journal:  Am J Trop Med Hyg       Date:  2012-11-05       Impact factor: 2.345

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection.

Authors:  Henrike J Vriend; Johannes A Bogaards; Jan E A M van Bergen; Antoinette A T P Brink; Ingrid V F van den Broek; Christian J P A Hoebe; Audrey J King; Marianne A B van der Sande; Petra F G Wolffs; Hester E de Melker
Journal:  Cancer Med       Date:  2015-07-21       Impact factor: 4.452

10.  Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control Study.

Authors:  Vitaly Smelov; Tarik Gheit; Karin Sundström; Alexander Ploner; Sandrine McKay-Chopin; Carina Eklund; Massimo Tommasino; Joakim Dillner
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more
  12 in total

1.  Chlamydia Trachomatis and Human Papillomavirus Serostatus in Puerto Rican Women.

Authors:  Maira A Castañeda-Avila; Erick Suárez-Pérez; Raúl Bernabe-Dones; Elizabeth R Unger; Gitika Panicker; Ana P Ortiz
Journal:  P R Health Sci J       Date:  2020-03       Impact factor: 0.705

2.  Bacterial sexually transmitted infections and syndromic approach: a study conducted on women at Moroccan University Hospital.

Authors:  Safae Karim; Chahrazed Bouchikhi; Abdelaziz Banani; Hinde El Fatemi; Tiatou Souho; Sanaa Erraghay; Bahia Bennani
Journal:  Germs       Date:  2021-12-29

Review 3.  Chlamydia Infection as a Risk Factor for Cervical Cancer: A Systematic Review and Meta-Analysis.

Authors:  Anaanthan Bhuvanendran Pillai; Chin Mun Wong; Noor Dalila Inche Zainal Abidin; Sharifah Fazlinda Syed Nor; Mohd Fathulzhafran Mohamed Hanan; Siti Rasidah Abd Ghani; Nurul Afzan Aminuddin; Nazarudin Safian
Journal:  Iran J Public Health       Date:  2022-03       Impact factor: 1.479

Review 4.  Unboxing the molecular modalities of mutagens in cancer.

Authors:  Smita Kumari; Sudhanshu Sharma; Dia Advani; Akanksha Khosla; Pravir Kumar; Rashmi K Ambasta
Journal:  Environ Sci Pollut Res Int       Date:  2021-10-05       Impact factor: 5.190

5.  Coinfection of High-Risk Human Papillomavirus and Lower Genital Tract Pathogens in the Development of High-Grade Cervical Lesions.

Authors:  Hui Zhong; Yao Tong; Haifeng Lin; Xiaodan Mao; Binhua Dong; Zhihui Wu; Huiyu Chen; Pengming Sun
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-08-30       Impact factor: 2.471

6.  Prevalence of Chlamydia trachomatis Infection Diagnosed by Polymerase Chain Reaction in Female Sex Workers in a Northern Mexican City.

Authors:  Luis Francisco Sánchez-Anguiano; Nadia Velázquez-Hernández; Fernando Martín Guerra-Infante; Marisela Aguilar-Durán; Alma Rosa Pérez-Álamos; Sergio Estrada-Martínez; José Antonio Navarrete-Flores; Ada Agustina Sandoval-Carrillo; Elizabeth Irasema Antuna-Salcido; Jesús Hernández-Tinoco; Cosme Alvarado-Esquivel
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2019-02-02

7.  Patients With LR-HPV Infection Have a Distinct Vaginal Microbiota in Comparison With Healthy Controls.

Authors:  Yunying Zhou; Lu Wang; Fengyan Pei; Mingyu Ji; Fang Zhang; Yingshuo Sun; Qianqian Zhao; Yatian Hong; Xiao Wang; Juanjuan Tian; Yunshan Wang
Journal:  Front Cell Infect Microbiol       Date:  2019-08-28       Impact factor: 5.293

8.  Vaginal Microbiota and Cytokine Microenvironment in HPV Clearance/Persistence in Women Surgically Treated for Cervical Intraepithelial Neoplasia: An Observational Prospective Study.

Authors:  Elisabetta Caselli; Maria D'Accolti; Erica Santi; Irene Soffritti; Sara Conzadori; Sante Mazzacane; Pantaleo Greco; Carlo Contini; Gloria Bonaccorsi
Journal:  Front Cell Infect Microbiol       Date:  2020-11-05       Impact factor: 5.293

9.  High molecular prevalence of HPV and other sexually transmitted infections in a population of asymptomatic women who work or study at a Brazilian university.

Authors:  Tamy Taianne Suehiro; Fabrícia Gimenes; Raquel Pantarotto Souza; Sergio Ken Iti Taura; Rita Cristina Cardoso Cestari; Mary Mayumi Taguti Irie; Cinthia Gandolfi Boer; Marcia Edilaine Lopes Consolaro; Vânia Ramos Sela da Silva
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-01-20       Impact factor: 1.846

10.  MicroRNA-183-5p Inhibits Aggressiveness of Cervical Cancer Cells by Targeting Integrin Subunit Beta 1 (ITGB1).

Authors:  Wei Zhang; Mingkai Zhang; Lantao Liu; Dan Jin; Pengyu Wang; Jing Hu
Journal:  Med Sci Monit       Date:  2018-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.